Study on body fat reducing effect of dietary supplement -A randomized, double blind, placebo-controlled, parallel group study- - Study on body fat reducing effect of dietary supplement

FANCL Corporation0 个研究点目标入组 100 人开始时间: 2017年9月8日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1)The candidate is currently undergoing drug or exercise therapy. 2)The candidate currently has, or has a history of, diabetes, liver disease, kidney disease, heart disease, any disease that affects corticosteroid secretion, and/or any other metabolic disease. 3)There are concerns about the potential for the study foods to induce allergic symptoms in the candidate. 4)The candidate is pregnant, or intends to become pregnant or to breastfeed during the study period. 5)The candidate generally or routinely takes any medication that affects body fat and/or lipid metabolism, including over-the-counter drugs, quasi-drugs, and health foods. 6)The candidate is currently dieting with the aim of reducing body weight. 7)The candidate has participated in any other clinical study within the past 1month.

发起方